Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Decreases By 84.4%

Key Points

• Short interest plunged 84.4% to 7,564 shares as of July 31, representing approximately 0.0% of outstanding shares and a negligible short-interest ratio.
• Shionogi reported quarterly EPS of $0.36, exceeding the $0.18 analyst consensus, while revenue of $1.04 billion also surpassed estimates.
• Analyst sentiment improved, with Goldman Sachs and Jefferies upgrading the ADR to “strong buy”; the stock’s average rating is now “Buy.”

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 31st, there was short interest totaling 7,564 shares, a decline of 84.4% from the July 15th total of 48,491 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 247,388 shares, the short-interest ratio is currently 0.0 days.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

Shares of OTCMKTS:SGIOY opened at $8.87 on Wednesday. Shionogi & Co., Ltd. Unsponsored ADR has a 12 month low of $7.65 and a 12 month high of $12.00. The stock has a market cap of $15.10 billion, a price-to-earnings ratio of 8.87, a PEG ratio of 3.49 and a beta of 0.08. The stock's 50 day moving average price is $8.78 and its 200 day moving average price is $9.87. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.58 and a quick ratio of 1.46.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 16.47% and a net margin of 46.67%.The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $970.69 million. Equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on SGIOY. Zacks Research upgraded Shionogi & Co., Ltd. Unsponsored ADR from a "strong sell" rating to a "hold" rating in a research report on Monday, May 25th. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research note on Monday, June 15th. Finally, Jefferies Financial Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy".

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company's product portfolio spans both established and innovative therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source